Ronald Blue Trust, Inc. Boston Scientific Corp Transaction History

Ronald Blue Trust, Inc.

$7.7 Billion
Q4 2024

A detailed history of Ronald Blue Trust, Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 4,425 shares of BSX stock, worth $462,368. This represents 0.01% of its overall portfolio holdings.

Number of Shares

4,425

Previous 15,077 70.65%

Holding current value

$462,368

Previous $1.35 Million 70.65%

% of portfolio

0.01%

Previous 0.02%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 30, 2025	SELL	$83.62 - $91.5 $890,720 - $974,658	-10,652 Reduced 70.65%	4,425 $395,000
Q4 2024 Jan 22, 2025	BUY	$83.62 - $91.5 $383,397 - $419,527	4,585 Added 43.7%	15,077 $1.35 Million
Q3 2024 Oct 17, 2024	BUY	$72.96 - $84.0 $366,040 - $421,428	5,017 Added 91.63%	10,492 $879,000
Q2 2024 Jul 18, 2024	BUY	$67.33 - $77.71 $164,083 - $189,379	2,437 Added 80.22%	5,475 $421,000
Q1 2024 May 01, 2024	BUY	$57.6 - $68.62 $89,452 - $106,566	1,553 Added 104.58%	3,038 $208,000
Q4 2023 Jan 18, 2024	BUY	$48.64 - $57.81 $6,906 - $8,209	142 Added 10.57%	1,485 $79,000
Q3 2023 Oct 11, 2023	BUY	$50.19 - $54.68 $3,914 - $4,265	78 Added 6.17%	1,343 $73,000
Q2 2023 Jul 14, 2023	SELL	$49.72 - $54.64 $45,294 - $49,777	-911 Reduced 41.87%	1,265 $63,000
Q1 2023 Apr 17, 2023	BUY	$45.09 - $50.03 $1,938 - $2,151	43 Added 2.02%	2,176 $100,000
Q4 2022 Jan 17, 2023	SELL	$39.56 - $47.22 $3,639 - $4,344	-92 Reduced 4.13%	2,133 $83,000
Q3 2022 Oct 21, 2022	SELL	$36.71 - $109.66 $14,684 - $43,864	-400 Reduced 15.24%	2,225 $83,000
Q2 2022 Aug 09, 2022	BUY	$35.24 - $47.1 $92,505 - $123,637	2,625 New	2,625 $116,000

Others Institutions Holding BSX

# of Institutions

1,663

Shares Held

1.22B

Call Options Held

8.76M

Put Options Held

9.42M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $150B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ronald Blue Trust, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ronald Blue Trust, Inc. with notifications on news.

Account

Ronald Blue Trust, Inc. Boston Scientific Corp Transaction History